Announcements Trials

Browse Landscape

Phase

Status

Completed 124 Recruiting 26 Unknown 23 Active not recruiting 23 Terminated 21 Withdrawn 3 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

zilucoplan 1 rozanolixizumab 1 fludarabine phosphate 1 fludarabine 1 exemestane 1 epigallocatechin gallate 1 durvalumab 1 aumolertinib 1 atropine sulfate-diphenoxylate hydrochloride drug combination 1 Vincristine 1 Tamoxifen 1 Sodium Chloride 1 R-CHOP protocol 1 Prednisone 1 Pemetrexed 1 Omeprazole 1 Melphalan 1 Loperamide 1 Letrozole 1 High-Energy Shock Waves 1 Gastroscopy 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Decitabine 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Catechin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Enrolling by invitation × Prednisone × Clear all

NCT07258680 2025-12-02

BrEto-TCL

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡